 open-label studi high-dos intraven immunoglobulin sever childhood asthma eight pediatr patient sever steroid-depend asthma open-label trial high-dos intraven immunoglobulin ivig attempt steroid requir monthli therapi high-dos ivig threefold decreas mainten oral corticosteroid dose extra oral corticosteroid control exacerb asthma signific improv peak expiratori flow rate symptom-scor rate immunomodulatori effect ivig chang immedi skin test reactiv seven patient reaction panel allergen therapi cours trial progress diminut skin test reactiv reduct sensit complet month therapi preliminari studi reduct steroid requir improv symptom flow measur diminut immedi skin test reactiv support potenti role ivig treatment sever steroid-depend asthma random trial